Omega-6 and trans fatty acids in blood cell membranes

A risk factor for acute coronary syndromes?

Robert C. Block, William Harris, Kimberly J. Reid, John A. Spertus

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Background: Although fatty acid intake has been associated with risk of coronary disease events, the association between blood omega-6 and trans fatty acids (FAs) at the time of an acute coronary syndrome (ACS) is unknown. Methods: The relationship of blood FA composition to ACS was analyzed in 768 incident cases and 768 controls (matched on age, sex, and race). Results: Compared to controls, ACS cases' blood cell membrane content of linoleic acid was 13% lower (P <.0001); arachidonic acid was 3.6% higher (P <.001); the trans isomer of oleic acid was 13.3% higher (P <.0001); and the trans-trans isomer of linoleic acid was 13.3% higher (P = .003). In multivariable analyses, a 1-SD decrease in linoleic acid was associated with >3 times the odds for being a case (odds ratio [OR] 3.23, 95% confidence interval [CI] 2.63-4.17). The relationship of arachidonic acid to ACS was U shaped; compared to the first quartile of arachidonic acid, the ORs for case status in the second, third, and fourth quartiles were 0.73 (95% CI 0.47-1.13), 0.65 (95% CI 0.41-1.04), and 2.32 (95% CI 1.39-3.90), respectively. The OR for a 1-SD increase in trans oleic acid was 1.24 (95% CI 1.06-1.45), and for trans-trans linoleic acid, 1.1 (95% CI 0.93-1.30). All associations were independent of membrane omega-3 FA content. Conclusions: High blood levels of linoleic acid but low levels of trans oleic acid are inversely associated with ACS. The relationship of arachidonic acid to ACS appears more complex.

Original languageEnglish (US)
Pages (from-to)1117-1123
Number of pages7
JournalAmerican Heart Journal
Volume156
Issue number6
DOIs
StatePublished - Dec 2008
Externally publishedYes

Fingerprint

Omega-6 Fatty Acids
Trans Fatty Acids
Acute Coronary Syndrome
Blood Cells
Cell Membrane
Confidence Intervals
Linoleic Acid
Arachidonic Acid
Oleic Acid
Fatty Acids
Odds Ratio
Omega-3 Fatty Acids
Coronary Disease
Membranes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Omega-6 and trans fatty acids in blood cell membranes : A risk factor for acute coronary syndromes? / Block, Robert C.; Harris, William; Reid, Kimberly J.; Spertus, John A.

In: American Heart Journal, Vol. 156, No. 6, 12.2008, p. 1117-1123.

Research output: Contribution to journalArticle

Block, Robert C. ; Harris, William ; Reid, Kimberly J. ; Spertus, John A. / Omega-6 and trans fatty acids in blood cell membranes : A risk factor for acute coronary syndromes?. In: American Heart Journal. 2008 ; Vol. 156, No. 6. pp. 1117-1123.
@article{d2f297924b9a4e9b8ea9e3e782a7df17,
title = "Omega-6 and trans fatty acids in blood cell membranes: A risk factor for acute coronary syndromes?",
abstract = "Background: Although fatty acid intake has been associated with risk of coronary disease events, the association between blood omega-6 and trans fatty acids (FAs) at the time of an acute coronary syndrome (ACS) is unknown. Methods: The relationship of blood FA composition to ACS was analyzed in 768 incident cases and 768 controls (matched on age, sex, and race). Results: Compared to controls, ACS cases' blood cell membrane content of linoleic acid was 13{\%} lower (P <.0001); arachidonic acid was 3.6{\%} higher (P <.001); the trans isomer of oleic acid was 13.3{\%} higher (P <.0001); and the trans-trans isomer of linoleic acid was 13.3{\%} higher (P = .003). In multivariable analyses, a 1-SD decrease in linoleic acid was associated with >3 times the odds for being a case (odds ratio [OR] 3.23, 95{\%} confidence interval [CI] 2.63-4.17). The relationship of arachidonic acid to ACS was U shaped; compared to the first quartile of arachidonic acid, the ORs for case status in the second, third, and fourth quartiles were 0.73 (95{\%} CI 0.47-1.13), 0.65 (95{\%} CI 0.41-1.04), and 2.32 (95{\%} CI 1.39-3.90), respectively. The OR for a 1-SD increase in trans oleic acid was 1.24 (95{\%} CI 1.06-1.45), and for trans-trans linoleic acid, 1.1 (95{\%} CI 0.93-1.30). All associations were independent of membrane omega-3 FA content. Conclusions: High blood levels of linoleic acid but low levels of trans oleic acid are inversely associated with ACS. The relationship of arachidonic acid to ACS appears more complex.",
author = "Block, {Robert C.} and William Harris and Reid, {Kimberly J.} and Spertus, {John A.}",
year = "2008",
month = "12",
doi = "10.1016/j.ahj.2008.07.014",
language = "English (US)",
volume = "156",
pages = "1117--1123",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Omega-6 and trans fatty acids in blood cell membranes

T2 - A risk factor for acute coronary syndromes?

AU - Block, Robert C.

AU - Harris, William

AU - Reid, Kimberly J.

AU - Spertus, John A.

PY - 2008/12

Y1 - 2008/12

N2 - Background: Although fatty acid intake has been associated with risk of coronary disease events, the association between blood omega-6 and trans fatty acids (FAs) at the time of an acute coronary syndrome (ACS) is unknown. Methods: The relationship of blood FA composition to ACS was analyzed in 768 incident cases and 768 controls (matched on age, sex, and race). Results: Compared to controls, ACS cases' blood cell membrane content of linoleic acid was 13% lower (P <.0001); arachidonic acid was 3.6% higher (P <.001); the trans isomer of oleic acid was 13.3% higher (P <.0001); and the trans-trans isomer of linoleic acid was 13.3% higher (P = .003). In multivariable analyses, a 1-SD decrease in linoleic acid was associated with >3 times the odds for being a case (odds ratio [OR] 3.23, 95% confidence interval [CI] 2.63-4.17). The relationship of arachidonic acid to ACS was U shaped; compared to the first quartile of arachidonic acid, the ORs for case status in the second, third, and fourth quartiles were 0.73 (95% CI 0.47-1.13), 0.65 (95% CI 0.41-1.04), and 2.32 (95% CI 1.39-3.90), respectively. The OR for a 1-SD increase in trans oleic acid was 1.24 (95% CI 1.06-1.45), and for trans-trans linoleic acid, 1.1 (95% CI 0.93-1.30). All associations were independent of membrane omega-3 FA content. Conclusions: High blood levels of linoleic acid but low levels of trans oleic acid are inversely associated with ACS. The relationship of arachidonic acid to ACS appears more complex.

AB - Background: Although fatty acid intake has been associated with risk of coronary disease events, the association between blood omega-6 and trans fatty acids (FAs) at the time of an acute coronary syndrome (ACS) is unknown. Methods: The relationship of blood FA composition to ACS was analyzed in 768 incident cases and 768 controls (matched on age, sex, and race). Results: Compared to controls, ACS cases' blood cell membrane content of linoleic acid was 13% lower (P <.0001); arachidonic acid was 3.6% higher (P <.001); the trans isomer of oleic acid was 13.3% higher (P <.0001); and the trans-trans isomer of linoleic acid was 13.3% higher (P = .003). In multivariable analyses, a 1-SD decrease in linoleic acid was associated with >3 times the odds for being a case (odds ratio [OR] 3.23, 95% confidence interval [CI] 2.63-4.17). The relationship of arachidonic acid to ACS was U shaped; compared to the first quartile of arachidonic acid, the ORs for case status in the second, third, and fourth quartiles were 0.73 (95% CI 0.47-1.13), 0.65 (95% CI 0.41-1.04), and 2.32 (95% CI 1.39-3.90), respectively. The OR for a 1-SD increase in trans oleic acid was 1.24 (95% CI 1.06-1.45), and for trans-trans linoleic acid, 1.1 (95% CI 0.93-1.30). All associations were independent of membrane omega-3 FA content. Conclusions: High blood levels of linoleic acid but low levels of trans oleic acid are inversely associated with ACS. The relationship of arachidonic acid to ACS appears more complex.

UR - http://www.scopus.com/inward/record.url?scp=56349113182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56349113182&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2008.07.014

DO - 10.1016/j.ahj.2008.07.014

M3 - Article

VL - 156

SP - 1117

EP - 1123

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 6

ER -